Bio-Rad Laboratories EBITDA 2010-2025 | BIO

Bio-Rad Laboratories EBITDA for the quarter ending March 31, 2025 was $0.024B, a 46.86% decline year-over-year.

  • Bio-Rad Laboratories 2024 EBITDA was 0.269B, a 20.37% decline from 2023.
  • Bio-Rad Laboratories 2023 EBITDA was 0.338B, a 30% decline from 2022.
  • Bio-Rad Laboratories 2022 EBITDA was 0.483B, a 3.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bio-Rad Laboratories EBITDA 2010-2025 | BIO

  • Bio-Rad Laboratories 2024 EBITDA was 0.269B, a 20.37% decline from 2023.
  • Bio-Rad Laboratories 2023 EBITDA was 0.338B, a 30% decline from 2022.
  • Bio-Rad Laboratories 2022 EBITDA was 0.483B, a 3.54% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$220.2B
Boston Scientific (BSX)$157B
Stryker (SYK)$154B
EssilorLuxottica (ESLOY)$136.6B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$50.3B
Haleon (HLN)$44.4B
ResMed (RMD)$40.3B
GE HealthCare Technologies (GEHC)$35.5B
Agilent Technologies (A)$34.1B
Terumo (TRUMY)$25.8B
Koninklijke Philips (PHG)$25.2B
Insulet (PODD)$20.4B
Zimmer Biomet Holdings (ZBH)$19.3B
Baxter (BAX)$15B
Smith & Nephew SNATS (SNN)$13.9B
Sunny Optical Technology (SNPTF)$10.4B
Demant (WILYY)$8.6B
Lantheus Holdings (LNTH)$5B
Perrigo (PRGO)$3.9B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.6B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.3B